Astrocyte Elevated Gene 1 Interacts with Acetyltransferase p300 and c-Jun To Promote Tumor Aggressiveness

REFERENCES

• Taran SJ, Taran R, Batra M, Ladia DD, Bhandari V. 2015. Survival with concurrent temozolomide and radiotherapy in pediatric brainstem glioma with relation to the tumor volume. J Pediatr Neurosci 10:341–345. https://doi.org/10.4103/1817-1745.174453.
   PubMedGoogle Scholar
• VandenDriessche T, Chuah MK. 2013. Glioblastoma: bridging the gap with gene therapy. Lancet Oncol 14:789–790. https://doi.org/10.1016/S1470-2045(13)70342-5.
   PubMedGoogle Scholar
• Su ZZ, Kang DC, Chen Y, Pekarskaya O, Chao W, Volsky DJ, Fisher PB. 2003. Identification of gene products suppressed by human immunodeficiency virus type 1 infection or gp120 exposure of primary human astrocytes by rapid subtraction hybridization. J Neurovirol 9:372–389. https://doi.org/10.1080/13550280390201263.
   PubMedGoogle Scholar
• Su ZZ, Kang DC, Chen Y, Pekarskaya O, Chao W, Volsky DJ, Fisher PB. 2002. Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH. Oncogene 21:3592–3602. https://doi.org/10.1038/sj.onc.1205445.
   PubMed Web of Science ®Google Scholar
• Su ZZ, Chen Y, Kang DC, Chao W, Simm M, Volsky DJ, Fisher PB. 2003. Customized rapid subtraction hybridization (RaSH) gene microarrays identify overlapping expression changes in human fetal astrocytes resulting from human immunodeficiency virus-1 infection or tumor necrosis factor-alpha treatment. Gene 306:67–78. https://doi.org/10.1016/S0378-1119(03)00404-9.
   PubMedGoogle Scholar
• Kang DC, Su ZZ, Sarkar D, Emdad L, Volsky DJ, Fisher PB. 2005. Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene 353:8–15. https://doi.org/10.1016/j.gene.2005.04.006.
   PubMedGoogle Scholar
• Emdad L, Sarkar D, Su ZZ, Randolph A, Boukerche H, Valerie K, Fisher PB. 2006. Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis. Cancer Res 66:1509–1516. https://doi.org/10.1158/0008-5472.CAN-05-3029.
   PubMed Web of Science ®Google Scholar
• Sarkar D, Park ES, Emdad L, Lee SG, Su ZZ, Fisher PB. 2008. Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1. Cancer Res 68:1478–1484. https://doi.org/10.1158/0008-5472.CAN-07-6164.
   PubMed Web of Science ®Google Scholar
• Thirkettle HJ, Mills IG, Whitaker HC, Neal DE. 2009. Nuclear LYRIC/AEG-1 interacts with PLZF and relieves PLZF-mediated repression. Oncogene 28:3663–3670. https://doi.org/10.1038/onc.2009.223.
   PubMed Web of Science ®Google Scholar
• Yoo BK, Santhekadur PK, Gredler R, Chen D, Emdad L, Bhutia S, Pannell L, Fisher PB, Sarkar D. 2011. Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma. Hepatology 53:1538–1548. https://doi.org/10.1002/hep.24216.
   PubMed Web of Science ®Google Scholar
• Blanco MA, Aleckovic M, Hua Y, Li T, Wei Y, Xu Z, Cristea IM, Kang Y. 2011. Identification of staphylococcal nuclease domain-containing 1 (SND1) as a Metadherin-interacting protein with metastasis-promoting functions. J Biol Chem 286:19982–19992. https://doi.org/10.1074/jbc.M111.240077.
   PubMed Web of Science ®Google Scholar
• Meng X, Zhu D, Yang S, Wang X, Xiong Z, Zhang Y, Brachova P, Leslie KK. 2012. Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein. J Biol Chem 287:4485–4491. https://doi.org/10.1074/jbc.C111.291518.
   PubMed Web of Science ®Google Scholar
• Yoo BK, Emdad L, Su ZZ, Villanueva A, Chiang DY, Mukhopadhyay ND, Mills AS, Waxman S, Fisher RA, Llovet JM, Fisher PB, Sarkar D. 2009. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest 119:465–477. https://doi.org/10.1172/JCI36460.
   PubMedGoogle Scholar
• Li G, Wang Z, Ye J, Zhang X, Wu H, Peng J, Song W, Chen C, Cai S, He Y, Xu J. 2014. Uncontrolled inflammation induced by AEG-1 promotes gastric cancer and poor prognosis. Cancer Res 74:5541–5552. https://doi.org/10.1158/0008-5472.CAN-14-0968.
   PubMedGoogle Scholar
• Yoo BK, Emdad L, Lee SG, Su ZZ, Santhekadur P, Chen D, Gredler R, Fisher PB, Sarkar D. 2011. Astrocyte elevated gene-1 (AEG-1): a multifunctional regulator of normal and abnormal physiology. Pharmacol Ther 130:1–8. https://doi.org/10.1016/j.pharmthera.2011.01.008.
   PubMedGoogle Scholar
• Brown DM, Ruoslahti E. 2004. Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell 5:365–374. https://doi.org/10.1016/S1535-6108(04)00079-0.
   PubMed Web of Science ®Google Scholar
• Lee SG, Su ZZ, Emdad L, Sarkar D, Fisher PB. 2006. Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc. Proc Natl Acad Sci U S A 103:17390–17395. https://doi.org/10.1073/pnas.0608386103.
   PubMed Web of Science ®Google Scholar
• Srivastava J, Siddiq A, Gredler R, Shen XN, Rajasekaran D, Robertson CL, Subler MA, Windle JJ, Dumur CI, Mukhopadhyay ND, Garcia D, Lai Z, Chen Y, Balaji U, Fisher PB, Sarkar D. 2015. Astrocyte elevated gene-1 and c-Myc cooperate to promote hepatocarcinogenesis in mice. Hepatology 61:915–929. https://doi.org/10.1002/hep.27339.
   PubMedGoogle Scholar
• Liu L, Wu J, Ying Z, Chen B, Han A, Liang Y, Song L, Yuan J, Li J, Li M. 2010. Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion. Cancer Res 70:3750–3759. https://doi.org/10.1158/0008-5472.CAN-09-3838.
   PubMed Web of Science ®Google Scholar
• Wang YN, Chen YJ, Chang WC. 2006. Activation of extracellular signal-regulated kinase signaling by epidermal growth factor mediates c-Jun activation and p300 recruitment in keratin 16 gene expression. Mol Pharmacol 69:85–98.
   PubMedGoogle Scholar
• Chen YJ, Wang YN, Chang WC. 2007. ERK2-mediated C-terminal serine phosphorylation of p300 is vital to the regulation of epidermal growth factor-induced keratin 16 gene expression. J Biol Chem 282:27215–27228. https://doi.org/10.1074/jbc.M700264200.
   PubMedGoogle Scholar
• Vries RG, Prudenziati M, Zwartjes C, Verlaan M, Kalkhoven E, Zantema A. 2001. A specific lysine in c-Jun is required for transcriptional repression by E1A and is acetylated by p300. EMBO J 20:6095–6103. https://doi.org/10.1093/emboj/20.21.6095.
   PubMed Web of Science ®Google Scholar
• Chang HJ, Park JS, Kim MH, Hong MH, Kim KM, Kim SM, Shin BA, Ahn BW, Jung YD. 2006. Extracellular signal-regulated kinases and AP-1 mediate the up-regulation of vascular endothelial growth factor by PDGF in human vascular smooth muscle cells. Int J Oncol 28:135–141.
   PubMed Web of Science ®Google Scholar
• Damert A, Ikeda E, Risau W. 1997. Activator-protein-1 binding potentiates the hypoxia-inducible factor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells. Biochem J 327(Pt 2):419–423.
   PubMed Web of Science ®Google Scholar
• Cho ML, Jung YO, Moon YM, Min SY, Yoon CH, Lee SH, Park SH, Cho CS, Jue DM, Kim HY. 2006. Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathways. Immunol Lett 103:159–166. https://doi.org/10.1016/j.imlet.2005.10.020.
   PubMed Web of Science ®Google Scholar
• Mathas S, Hinz M, Anagnostopoulos I, Krappmann D, Lietz A, Jundt F, Bommert K, Mechta-Grigoriou F, Stein H, Dorken B, Scheidereit C. 2002. Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B. EMBO J 21:4104–4113. https://doi.org/10.1093/emboj/cdf389.
   PubMed Web of Science ®Google Scholar
• Assimakopoulou M, Kondyli M, Gatzounis G, Maraziotis T, Varakis J. 2007. Neurotrophin receptors expression and JNK pathway activation in human astrocytomas. BMC Cancer 7:202. https://doi.org/10.1186/1471-2407-7-202.
   PubMedGoogle Scholar
• Lopez-Bergami P, Lau E, Ronai Z. 2010. Emerging roles of ATF2 and the dynamic AP1 network in cancer. Nat Rev Cancer 10:65–76. https://doi.org/10.1038/nrc2681.
   PubMedGoogle Scholar
• Cui J, Wang Q, Wang J, Lv M, Zhu N, Li Y, Feng J, Shen B, Zhang J. 2009. Basal c-Jun NH2-terminal protein kinase activity is essential for survival and proliferation of T-cell acute lymphoblastic leukemia cells. Mol Cancer Ther 8:3214–3222. https://doi.org/10.1158/1535-7163.MCT-09-0408.
   PubMed Web of Science ®Google Scholar
• Cui J, Han SY, Wang C, Su W, Harshyne L, Holgado-Madruga M, Wong AJ. 2006. c-Jun NH(2)-terminal kinase 2alpha2 promotes the tumorigenicity of human glioblastoma cells. Cancer Res 66:10024–10031. https://doi.org/10.1158/0008-5472.CAN-06-0136.
   PubMed Web of Science ®Google Scholar
• Tsuiki H, Tnani M, Okamoto I, Kenyon LC, Emlet DR, Holgado-Madruga M, Lanham IS, Joynes CJ, Vo KT, Wong AJ. 2003. Constitutively active forms of c-Jun NH2-terminal kinase are expressed in primary glial tumors. Cancer Res 63:250–255.
   PubMedGoogle Scholar
• Uchida C, Gee E, Ispanovic E, Haas TL. 2008. JNK as a positive regulator of angiogenic potential in endothelial cells. Cell Biol Int 32:769–776. https://doi.org/10.1016/j.cellbi.2008.03.005.
   PubMedGoogle Scholar
• Debinski W, Gibo D, Mintz A. 2003. Epigenetics in high-grade astrocytomas: opportunities for prevention and detection of brain tumors. Ann N Y Acad Sci 983:232–242. https://doi.org/10.1111/j.1749-6632.2003.tb05978.x.
   PubMed Web of Science ®Google Scholar
• Eferl R, Wagner EF. 2003. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3:859–868. https://doi.org/10.1038/nrc1209.
   PubMed Web of Science ®Google Scholar
• Wagner EF, Nebreda AR. 2009. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9:537–549. https://doi.org/10.1038/nrc2694.
   PubMed Web of Science ®Google Scholar
• Vivanco I, Palaskas N, Tran C, Finn SP, Getz G, Kennedy NJ, Jiao J, Rose J, Xie W, Loda M, Golub T, Mellinghoff IK, Davis RJ, Wu H, Sawyers CL. 2007. Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN. Cancer Cell 11:555–569. https://doi.org/10.1016/j.ccr.2007.04.021.
   PubMed Web of Science ®Google Scholar
• Lamph WW, Wamsley P, Sassone-Corsi P, Verma IM. 1988. Induction of proto-oncogene JUN/AP-1 by serum and TPA. Nature 334:629–631. https://doi.org/10.1038/334629a0.
   PubMed Web of Science ®Google Scholar
• Herdegen T, Waetzig V. 2001. AP-1 proteins in the adult brain: facts and fiction about effectors of neuroprotection and neurodegeneration. Oncogene 20:2424–2437. https://doi.org/10.1038/sj.onc.1204387.
   PubMed Web of Science ®Google Scholar
• Li J, Zhang N, Song LB, Liao WT, Jiang LL, Gong LY, Wu J, Yuan J, Zhang HZ, Zeng MS, Li M. 2008. Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin Cancer Res 14:3319–3326. https://doi.org/10.1158/1078-0432.CCR-07-4054.
   PubMedGoogle Scholar